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Abstract
The progressive depletion of CD4 T cells underlies clinical progression to AIDS in untreated HIV-
infected subjects. Most dying CD4 T cells correspond to resting nonpermissive cells residing in 
lymphoid tissues. Death is due to an innate immune response against the incomplete cytosolic 
viral DNA intermediates accumulating in these cells. The viral DNA is detected by the IFI16 
sensor leading to inflammasome assembly, caspase 1 activation, and the induction of pyroptosis, a 
highly inflammatory form of programmed cell death. We now show that cell-to-cell transmission 
of HIV is obligatorily required for activation of this death pathway. Cell-free HIV-1 virions, even 
when added in large quantities, fail to activate pyroptosis. These findings underscore the infected 
CD4 T cells as the major killing units promoting progression to AIDS and highlight a previously 
unappreciated role for the virological synapse in HIV pathogenesis.
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The primary cause of AIDS in subjects is the progressive loss of CD4 T cells due to HIV 
infection (Thomas, 2009). The depletion of these cells has often been studied using cell-free 
virions infections of activated blood-derived CD4 T cells because of their ready availability 
and capacity to support productive viral infection (Cooper et al., 2013). However, the 
cytopathic response to HIV is not restricted to productively infected cells. Indeed, most 
dying CD4 T-cells in lymphoid tissues are resting cells that cannot support productive 
infection, and instead become abortively infected (Doitsh et al., 2010). We have used an ex 
vivo human lymphoid aggregate culture (HLAC) system formed with fresh human tonsil 
tissues to study CD4 T cell death during HIV infection (Glushakova et al., 1995). HLACs 
can be infected with a small number of viral particles in the absence of exogenous mitogens, 
allowing analysis of HIV-1 cytopathicity in a natural and preserved lymphoid 
microenvironment (Eckstein et al., 2001). Infection of HLACs with HIV-1 produces 
extensive loss of CD4 T cells — less than 5% of the cells die as a result of productive viral 
infection while >95% of them die as a consequence of abortive infection (Doitsh et al., 
2010). Due to the nonpermissive nature of these quiescent cells, the viral lifecycle attenuates 
during chain elongation phase of reverse transcription, giving rise to incomplete transcripts 
of cytosolic viral DNA. These intermediates are sensed by interferon gamma inducible 
protein 16 (IFI16) (Monroe et al., 2014), which activates caspase 1 in inflammasomes 
leading in turn to pyroptosis, a highly inflammatory form of programmed cell death (Doitsh 
et al., 2014).
Retroviruses disseminate between susceptible cells either by cell-free infection or by direct 
cell-to-cell spread (Sattentau, 2010). The advantage of cell-to-cell spread on viral infectivity 
has been recognized for two decades (Jolly and Sattentau, 2004; Lehmann et al., 2011; 
Phillips, 1994; Sato et al., 1992; Sourisseau et al., 2007). For HIV-1, the infectivity of virus-
producing cells, as measured in co-culture systems, is approximately 102 to 103 times higher 
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than the infectivity of cell-free particles from the same infected cells (Jolly, 2011). However, 
in the context of pathogenesis, it was unclear whether transfer of HIV-1 through cell-to-cell 
contact triggers the same innate immune responses as cell-free particles in resting CD4 T 
cells, the predominant target cells depleted by HIV in lymphoid tissues.
RESULTS
The mode of HIV-1 transfer markedly affects the death response in target lymphoid CD4 T 
cells
Most studies examining innate immune recognition of HIV-1 have utilized cell-free particles 
and characterized responses occurring in dendritic cells or macrophages (Gao et al., 2013; 
Hayashi et al., 2010; Jakobsen et al., 2013; Lahaye et al., 2013; Manel et al., 2010; Sun et 
al., 2013; Yan et al., 2010). More recently, attention has focused on resting CD4 T cells in 
lymphoid tissue, which are mostly non-permissive for productive HIV infection. We 
previously have shown that the massive death of lymphoid CD4 T cells that are abortively 
infected with HIV-1 requires close interaction between uninfected target and HIV-producing 
cells (Doitsh et al., 2010). These findings were consistent with in vitro (Garg et al., 2007; 
Holm and Gabuzda, 2005) and in vivo (Finkel et al., 1995) studies showing that dying non-
productively infected cells in human lymph nodes often cluster near productively infected 
cells (Finkel et al., 1995). In contrast, we found that cell-free virions accumulating in the 
supernatants of HIV-infected HLACs, even at high concentrations, were much less efficient 
at inducing killing of resting target cells by abortive infection. One potential explanation for 
these differences was that transfer of cell-free particles may not generate sufficient 
incomplete reverse DNA transcripts to induce a cytopathic response in target CD4 T cells. 
Cell-to-cell spread increases infection kinetics by two to three orders of magnitude by 
directing virus assembly and obviating the rate-limiting step of extracellular diffusion 
required for cell-free virus to find and engage a susceptible target cell (Jolly, 2011; Martin 
and Sattentau, 2009; Sato et al., 1992; Sourisseau et al., 2007).
To test this hypothesis, we used spinoculation to emulate efficient cell-to-cell spread of virus 
(Geng et al., 2014). Spinoculation accelerates the binding of cell-free virions to target cells, 
facilitates synchronized delivery of a large number of particles into the cells (O’Doherty et 
al., 2000; Saphire et al., 2002), and enhances accumulation of cytoplasmic reverse DNA 
transcripts (Figure 1A) (O’Doherty et al., 2000; Pace et al., 2012). As expected, 
spinoculation of HLACs with free HIV-1 promoted high levels of HIV-1 fusion into target 
lymphoid CD4 T cells (Figure S1). Spinoculation also caused extensive and selective 
depletion of target CD4 T cells (Figure 1B). The relative proportion of CD8 T cells was 
unaltered. CD3+/CD8− T cells were similarly depleted, indicating that cell loss was not an 
artifact of down-regulated surface expression of CD4 following direct infection (not shown). 
Consistent with our previous reports (Doitsh et al., 2010; Doitsh et al., 2014; Monroe et al., 
2014), loss of CD4 T cells was prevented by addition of efavirenz, an NNRTI that 
allosterically inhibits HIV-1 reverse transcriptase, and by AMD3100, an entry inhibitor that 
blocks gp120 engagement of the CXCR4 coreceptor. However, unexpectedly and not in 
keeping with our previous reports, addition of raltegravir, an integrase inhibitor also blocked 
CD4 T-cell death (Figure 1B and S5). Because cell death involves viral life cycle events 
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occurring prior to viral integration, raltegravir should act too late to affect the abortive 
infection process that triggers the pyroptotic response.
To further investigate this surprising result, CFSE-labeled target CD4 T cells were co-
cultured with productively infected HLACs and raltegravir was added at the time of mixing 
of productively infected and target CD4 T cells (Figure 1C). Under these conditions, 
raltegravir had no effect on target CD4 T-cell death while efavirenz and AMD3100 blocked 
the response (Figure 1D).
Free HIV-1 particles do not induce cell death of target lymphoid CD4 T cells
Based on these contrasting effects of raltegravir, we hypothesized that in the co-culture 
experiments involving mixing of HIV-infected HLACs with target cells, raltegravir had no 
effect on the ensuing death of target CD4 T cells that became abortively infected because the 
culture already contained productively infected cells. Conversely, in the spinoculation 
experiments, raltegravir blocked cell death because it prevented the establishment of a 
productively infected subset of cells needed for cell-to-cell spread the virus to target CD4 T 
cells. To test this hypothesis, we spinoculated HLACs with either single-round or multiple-
round viruses containing a GFP reporter (NLENG1I) (Levy et al., 2004). These viruses 
permit the dynamics of HIV-1 infection and T-cell depletion to be simultaneously monitored 
in the spinoculated cultures. Four days after spinoculation, we observed a similar number of 
GFP-positive, productively infected cells with both the single-round and multiple round 
viruses, indicating that viral spread was not required to establish an initial population of 
productively infected cells. However, we observed a massive loss of CD4 T cells only in 
cultures spinoculated with the multiple-round virus. Notably, spinoculation with an 
integrase-deficient GFP HIV-1 (NLENG1I-D116N) (Gelderblom et al., 2008) resulted in no 
productive infection and no CD4 T-cell death (Figure 2A). These results suggested that viral 
spread from productively infected cells, but not spinoculation of cell-free virions, is 
promoting the death of non-permissive lymphoid CD4 T cells. In agreement with this 
conclusion, addition of the AMD3100 entry inhibitor four hours after spinoculation 
efficiently blocked the ensuing death response while not affecting the number of GFP-
positive productively infected cells (Figure 2B). Moreover, treatment with the viral protease 
inhibitor saquinavir, which acts during the budding stage of HIV-1 replication, did not 
inhibit productive infection but prevented CD4 T-cell death by newly released HIV-1 
virions (Figure S2). These findings further indicated that CD4 T-cell death occurs after 
establishment of productive infection, but not during infection with cell-free viruses.
Single-round and integrase-deficient HIV-1 clones are not competent for cell-to-cell 
dissemination following spinoculation with HLACs. To confirm that the mode of viral 
transfer influenced the death response of target CD4 T cells, we modified the infection 
system by overlaying HLACs on a monolayer of 293T cells that had been transfected with 
these single-round proviral clones (Figure 2C). Interestingly, when these single-round 
viruses were transferred to HLACs by direct interaction with virus-producing 293T cells, a 
massive killing of target lymphoid CD4 T cells was observed (Figure 2D). These results 
demonstrate that recapitulating the cell-to-cell mode of viral transfer is sufficient to restore 
the killing capacity of these single-round clones.
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The death response involves cell adhesion molecules required for virological synapse 
formation
To further explore whether cell-cell contact was needed to induce death of CD4 T cells, we 
repeated the co-culture assay using productively infected and target CFSE-labeled HLACs. 
However, in this experiment the cells were co-cultured under conditions of increasing 
surface area thereby reducing the likelihood of cell-cell interactions. Using flow cytometry, 
we analyzed the levels of viable target CD4 T cells in the plates every 24 hours during four 
days of co-culture. The death of target CD4 T cells decreased as the surface area of the 
culture increased (Figure 3A), even in samples where the volume of culture medium 
remained constant (Figure 3B). These data suggest that the physical distance between HIV-
producing and target cells directly affects the kinetics of CD4 T-cell depletion, and argue 
further against a role for free virions released into the medium in the death response.
Cell-to-cell spread of HIV-1 predominantly takes place across specialized contact-induced 
structures known as virological synapses (Agosto et al., 2015; Jolly et al., 2004; Jolly et al., 
2007; Jolly and Sattentau, 2004). These synapses facilitate efficient transmission of virus 
toward the uninfected and engaged target cell. The synapse gains stability through a rapid 
actin-mediated recruitment of adhesion molecules, such as the integrin leukocyte function-
association antigen 1 (LFA-1) and its cognate ligand ICAM-1 to the junction point of 
cellular interaction (Jolly et al., 2007). To examine whether virological synapse formation 
between HIV-infected and target cells is required to promote CD4 T-cell death, productively 
infected and target CFSE-labeled HLACs were co-cultured in the presence of blocking 
antibodies against ICAM-1 or CD11a, the α-subunit of the LFA-1 heterodimer. Addition of 
either the anti-ICAM-1 (Figure 3C) or anti-CD11a (Figure 3D) antibodies, but not isotype 
matched control antibodies, effectively blocked depletion of target CD4 T cells in the mixed 
cultures as efficiently as the antiviral drug efavirenz. These findings suggest that the death 
response involves adhesion molecules that are required for virological synapse formation, 
indicative of a requirement for close cell-cell contact in mediating pyroptotic cell death. 
Because cell-free virions also express LFA-1 and ICAM-1 (Bounou et al., 2002; Fortin et 
al., 1997), we cannot completely rule out an additional effect on HIV virions. However, 
when combined with all of the data (Figure S2), we conclude that cell-to-cell transmission is 
critical for the induction of pyroptosis.
Western blotting analysis of HLAC revealed high expression levels of ICAM-1 in B cells, 
but not in CD4 or CD8 T lymphocytes. However, activated CD4 T cells, which correspond 
to those that become productively infected with HIV-1, express high levels of this adhesion 
molecule (Figure 3E). In contrast to ICAM-1, CD11a expression levels were high in both 
resting and activated CD4 T cells (Figure 3F). Thus, synapse formation between activated 
CD4 T cells expressing ICAM-1 and target CD4 T cells (either activated or resting) 
expressing LFA-1 may occur regularly in lymphoid tissues.
Caspase 1 activation in abortively infected cells requires cell-to-cell spread of HIV-1
Most CD4 T cells in lymphoid tissues infected with HIV die by caspase 1-mediated 
pyroptosis triggered by abortive viral infection (Doitsh et al., 2014). To test whether caspase 
1 is induced by cell-free HIV-1 particles or by cell-to-cell spread of HIV-1, we spinoculated 
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HLACs with single-round or multiple-round clones of a DsRedExpress reporter virus 
(NLRX-IRES) (Gelderblom et al., 2008), and analyzed intracellular caspase 1 activity using 
cell permeable fluorogenic caspase 1 specific substrates (CaspaLux1) (Komoriya et al., 
2000; Packard and Komoriya, 2008). Consistent with our previous reports (Doitsh et al., 
2014; Monroe et al., 2014), spinoculation with multiple-round HIV-1 particles triggered 
high levels of intracellular caspase 1 activity in target CD4 T cells. In contrast, spinoculation 
with single-round or integrase-deficient HIV-1 particles produced only background levels of 
caspase 1 activity (Figure 4A). Inhibition of cell-to-cell spread using the viral protease 
inhibitor saquinavir, or by treatment with AMD3100 four hours after spinoculation, also 
markedly inhibited caspase 1 activation induced by multiple-round HIV-1 particles.
Consistent with pyroptosis as the pathway of programmed cell death, spinoculation with 
multiple-round HIV particles resulted in the release of the intracellular enzyme lactate 
dehydrogenase (LDH) (Fink and Cookson, 2005) (Figure 4B). Further, the release of LDH 
was completely blocked when AMD3100 was added four hours after spinoculation or when 
single-round or integrase-deficient HIV-1 particles were used for initial infection. Together, 
these findings indicate that infection with cell-free HIV-1 particles does not lead to caspase 
1 activation despite apparent abortive infection of lymphoid CD4 T cells. Rather, capsase-1 
activation and the induction of pyroptosis require the generation of productively infected 
cells and successful cell-to-cell spread of HIV-1 to quiescent bystander lymphoid CD4 T 
cells.
DISCUSSION
The life cycle of HIV-1 involves the release of particles into the extracellular space, 
followed by spread to distant susceptible cellular hosts. HIV-1 can also spread directly from 
productively infected cells to neighboring cells through virological synapses, a process that 
is 102 to 103 fold more efficient than infection with cell free virions. Despite the high 
efficiency of this mode of viral transmission, most HIV-1 pathogenesis research has 
involved the study of cell-free viruses (Cummins and Badley, 2010; Fevrier et al., 2011) in 
part because highly permissive cells, such as activated peripheral blood lymphocytes, have 
been used as cellular targets. These cells are fully permissive to HIV infection and give rise 
to new virions but then die primarily by caspase 3-mediated apoptosis (Cooper et al., 2013; 
Gougeon et al., 1996). However, in human lymphoid tissues such as tonsil and spleen, 
activated and permissive cells represent only 5% of the total CD4 T cell population. Far 
more commonly, HIV enters resting non-permissive cells that represent >95% of the CD4 T 
cell population (Doitsh et al., 2010; Eckstein et al., 2001; Moore et al., 2004). These non-
permissive cells undergo abortive infection and ultimately die due to an innate immune 
response launched by the host against cytosolic viral DNA culminating in caspase 1-
dependent pyroptosis, a highly inflammatory form of programmed cell death (Doitsh et al., 
2014; Monroe et al., 2014).
Here, we explored the death of lymphoid CD4 T cells in HLACs using experimental 
strategies that unambiguously distinguish between cell-free and cell-to-cell modes of HIV-1 
transmission. Using this system we now demonstrate that the mode of HIV-1 spread 
determines the outcome form of cell death. Specifically, cell-to-cell spread of HIV-1 is 
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required to deplete non-permissive lymphoid CD4 T cells via caspase 1-dependent 
pyroptosis. Free HIV-1 particles, even when added in large quantities, are unable to trigger 
innate immune recognition leading to pyroptosis. Conversely, infection with free HIV-1 
particles does cause a small fraction of permissive cells in HLACs to become productively 
infected. It is these cells that mediate cell-to-cell spread culminating in the pyroptotic death 
on nonpermissive CD4 T cells. These findings suggest a radical change in the prevailing 
view of HIV pathogenesis where most of the pathogenic effects of HIV-1 are attributed to 
killing of CD4 T cells by circulating free virions. We propose that the fundamental “killing 
units” of CD4 T cells leading to CD4 T-cell depletion and ultimately progression to AIDS 
are predominantly infected cells residing in lymphoid tissues that mediate cell-to-cell spread 
of the virus. Productive (“direct”) and abortive (“bystander”) infections are often viewed as 
independent pathways underlying the progressive depletion of CD4 T cells (Cooper et al., 
2013; Doitsh et al., 2010; Doitsh et al., 2014). Our findings now show that productive and 
abortive infections are not independent cytopathic events, but rather are linked in a single 
pathogenic cascade (Figure 5). Productively infected cells are obligatorily required to 
transmit the virus across the virological synapse formed with resting CD4 T cells. The 
productively infected cell ultimately dies by apoptosis, while the bystander resting cell dies 
by pyroptosis.
The interaction of the cognate adhesion molecules ICAM-1 and LFA-1 at the virological 
synapse is critically important for efficient HIV-1 spread between permissive effector and 
target CD4 T cells. Our findings in HLACs demonstrate the role of the virological synapse 
in viral infection and depletion of non-permissive CD4 T-cell targets. Human lymphoid 
tissues predominantly consist of non-permissive CD4 T cells (Doitsh et al., 2010; Doitsh et 
al., 2014; Eckstein et al., 2001; Glushakova et al., 1995). Therefore, the interaction and 
formation of virological synapses between productively infected cells expressing ICAM-1 
and non-permissive targets expressing LFA-1 likely occur at high frequency in the T cell 
zone found in HIV-infected lymphoid tissues and centrally contribute to the 
immunopathogenic effects of HIV-1. The interaction of LFA-1 on T cells with ICAM-1 also 
mediates the arrest and migration of T cells on surfaces of postcapillary venules at sites of 
infection or injury, as well as the ability of these cells to crawl out of the blood stream 
between high endothelial venules and into lymph nodes (Girard et al., 2012). Importantly, 
interleukin (IL)-1β increases the expression of adhesion molecules such as ICAM-1 on 
endothelial cells (Dinarello, 2009; Dustin et al., 2011; Hubbard and Rothlein, 2000). The 
release of IL-1β by dying pyroptotic CD4 T cells in HIV-infected lymphoid tissues likely 
attracts more cells from the blood into the infected lymph nodes to die and produce more 
inflammation. Thus, the interaction of LFA-1 with ICAM-1 contributes to a pathogenic 
cycle occurring during HIV infection by both promoting the depletion of CD4 T cells and 
facilitating a state of chronic inflammation, two key processes that propel clinical 
progression of disease ultimately culminating in AIDS (Deeks, 2011).
The molecular mechanisms that limit pyroptosis to virus transmission occurring via the cell-
to-cell route are unknown. One possibility relates to TREX1, a cellular 3′ DNA exonuclease, 
and SLX4-associated MUS81-EME1 endonucleases that function as “cytoplasmic cleaners” 
that degrade single- and double-stranded DNA, respectively (Laguette et al., 2014; Stetson 
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et al., 2008). Indeed, the intrinsic action of the TREX1 and SLX4-associated endonucleases 
in the cytoplasm may set a threshold level for reverse-transcribed DNA products needed for 
either productive infection in permissive cells, or, alternatively, pyroptosis in abortively 
infected non-permissive cells (Laguette et al., 2014; Yan et al., 2010). Cell-to-cell spread 
across the virological synapse may overcome TREX1/SLX4-mediated restriction by rapidly 
transferring large quantities of viral nucleic acid to the opposing target cell. Ironically, while 
this mechanism likely evolved for efficient viral spread between permissive cells, it acts 
against HIV-1 in non-permissive targets where it triggers abortive infection and pyroptosis 
that drives inflammation and disease in the host.
EXPERIMENTAL PROCEDURES
Preparation of HIV-1 Virions
Replication-competent HIV-1 virions were produced using the X4-tropic reporter NL4-3 
clones of HIV-1. For replication-competent reporter viruses we use the NLENG1-IRES 
(NLENG1I), and a DsRedExpress reporter NLRX-IRES (NLRXI). All virus stocks were 
quantitated by measuring p24gag levels by Elisa (Perkin Elmer, Cat # NEK050B001KT). 
Please see our Supplemental Experimental Procedures for a detailed experimental protocol.
FACS Analysis and Gating Strategy
Cell death was determined in co-culture systems by gating on live cells with forward and 
side scatter, followed by gating and counting of CD4 and CD8 T cells. The survival 
percentage of CD4 T cells was calculated by dividing the number of CD4 T cells by that of 
CD8 T cells. All conditions were normalized to uninfected conditions. For a detailed 
description to our method of measuring and calculating the levels of CD4 T-cell death in 
HIV-infected HLACs see Figure S4. Viable cells were also detected using Zombie Red 
(BioLegend, Cat # 423105), a fluorescent dye that is non-permeant to live cells, but 
permeant to the cells with compromised membranes. The results showed a close 
concordance to the experimental approach using gating on forward scatter versus side scatter 
(Figure S5). Please see our Supplemental Experimental Procedures for a complete 
experimental description.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The mode of HIV-1 spread determines the outcome form of cell death
Cell-to-cell spread is required to deplete non-permissive CD4 T cells via pyroptosis
Free HIV-1 particles, even in large quantities, are unable to trigger pyroptosis
The fundamental “killing units” of CD4 T cells are infected cells, not the virus.
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Figure 1. The mode of HIV-1 transfer generates disparate death responses of target lymphoid 
CD4 T cells
The death of lymphoid CD4 T cells was examined by spinoculation of target cells with large 
quantities of cell-free virions to target cells (A, B), as previously described (Doitsh et al., 
2014; Geng et al., 2014; O’Doherty et al., 2000), or in co-cultures of CFSE-labeled target 
CD4 T with productively infected HLACs (Doitsh et al., 2010; Jekle et al., 2003) (C, D). All 
samples were infected with a multiple-round X4-tropic NL4-3 strain of HIV-1. NL4-3 was 
selected because tonsillar tissue contains a high percentage of resting CD4 T cells that 
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express CXCR4 (90–100%). Target cells were treated with the same concentrations of drugs 
prior to co-culture with productively infected HLACs or spinoculation with free virions. 
Inhibitors blocking HIV entry (AMD3100) or early steps of reverse transcription (efavirenz) 
prevented death of target CD4 T cells. In sharp contrast, inhibiting later events in the viral 
life cycle (raltegravir) did not prevent cell death in co-cultures with productively infected 
cells (B), but abrogated the death response of target cells spinoculated with cell-free HIV-
particles (D). Bar graph represents summary of flow data presented. Error bars represent SD/
√n (SEM) of three independent donors. FACS plots are representative of six independent 
experiments performed with tonsils from different donors. See also Figure S1.
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Figure 2. Free HIV-1 particles do not induce cell death of abortively infected lymphoid CD4 T 
cells
(A) HLACs were spinoculated with a multiple-round (NLENG1I), a single-round 
(NLENG1-ES-IRES, pseudotyped with HIV-1 Env), or integrase deficient (NLENG1I-
D116N) viral clones containing a GFP reporter. An IRES upstream of the nef gene preserves 
Nef expression and supports LTR-driven GFP expression in productively infected target 
cells (Levy et al., 2004). No drugs were added to the spinoculated cultures. The levels of 
productive infection and CD4 T-cell depletion in the cultures were analyzed by flow 
cytometry four days after spinoculation. (B) Treatment with the entry inhibitor AMD3100 
four hours after spinoculation with multiple-round NLENG1I HIV-1 particles does not 
prevent productive infection, but efficiently blocks the killing of target resting CD4 T cells. 
Thus, death of CD4 T cells occurs after establishment of productive infection, but not during 
initial spinoculation of cell-free viruses. Of note, spinoculation of supernatant from infected 
HLACs failed to induce death of target CD4 T cells (See Figure S3). (C) A method to assess 
death of CD4 T cells with non-infectious HIV-1 clones. The single-round and integrase-
deficient HIV-1 clones are not competent for multiple rounds of viral replication. Instead, 
we modified the experimental system by overlaying HLAC cells on a monolayer of 293T 
cells transfected with these proviral clones, as previously described (Doitsh et al., 2014). As 
illustrated, fresh human tonsil is processed into HLAC and cells are cultured in suspension. 
After 12 hours, transfected 293T cells in a 24-well plate are washed and overlaid with 4×106 
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HLAC cells in RPMI. Virus-producing 293T cells directly interact with target overlaying 
HLAC cells. After 24–72 hours, HLAC suspensions were collected from wells and analyzed 
by flow cytometry. (D) Single-round and integrase-deficient HIV-1 clones kill target CD4 T 
cells as efficiently as multiple-round HIV-1 clones when transmitted via virus-producing 
cells. FACS plots are representative of three independent experiments performed with 
tonsils from different donors. Error bars, SEM; *** P < 0.001 (Student’s t test); n.s., not 
significant, P > 0.05. See also Figure S2.
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Figure 3. Death of lymphoid CD4 T cells requires close interaction with productively infected 
cells
(A) Increasing the cell culture surface area in HIV-infected cultures decreases cell-to-cell 
interactions, and reduces the kinetics of CD4 T-cell depletion. (B) Inverse correlation 
between culture surface area and CD4 T-cell death. Death of target CD4 T cells in each 
vessel was examined after four days of co-culturing with HIV-infected cells. Note that cell 
death decreases even in vessels where the volume of culture medium remained constant. (C, 
D) Blocking antibodies against either ICAM-1 or CD11a prevent death of target CD4 T cells 
(E) Exclusive expression of ICAM-1 on activated (permissive) lymphoid CD4 T cells. 
ICAM-1 expression is also high in antigen presenting B cells, but not CD8 T cells. (F) High 
expression of LFA-1 on lymphoid CD4 and CD8 T cells, but not on B cells. In contrast to 
ICAM-1, LFA-1 expression is not increased on activated CD4 T cells. Error bars, SEM; *P 
< 0.05, ***P < 0.001 (Student’s t test). EFV, Efavirenz. See also Figures S3, S4, and S5.
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Figure 4. Cell-to-Cell transmission of HIV-1 is required to trigger innate recognition and caspase 
1-dependent pyroptosis of lymphoid CD4 T Cells
(A) HLACs were spinoculated with multiple- or single-round NLRX-IRES reporter clones 
as indicated. Saquinavir was added to the culture before spinoculation. AMD3100 was 
added to the culture four hours after spinoculation. Cells were analyzed by flow cytometry 
using cell permeable fluorogenic substrates that contain amino acids sequences specifically 
cleaved by active caspase 1 (CaspaLux1). Abundant caspase 1 activity is exclusively 
observed in cultures spinoculated with multiple-round HIV-1 clones. Essentially no caspase 
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1 activity is observed in target CD4 T cells where cell-to-cell spread of HIV-1 is blocked or 
does not occur. Histograms show one experiment, a representative of three independent 
experiments performed with tonsils from different donors (B) Supernatants from 
spinoculated cultures were analyzed for levels of released cytoplasmic LDH enzyme, an 
indicator of pyroptosis (Decker and Lohmann-Matthes, 1988) FACS plots are representative 
of three independent experiments performed with tonsils from different donors. Error bars, 
SEM; **P < 0.01 (Student’s t test). See also Figure S5.
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Figure 5. The mode of HIV-1 spread determines the outcome form of cell death
Infection of free HIV-1 particles produces productive infection and caspase 3-apoptosis in a 
small fraction of permissive lymphoid CD4 T cells. Next, cell-to-cell spread of HIV-1 is 
required to deplete the non-permissive lymphoid CD4 T cells, which represent 95% or more 
of the target cells in lymphoid tissues, via caspase 1-dependent pyroptosis. Free HIV-1 
particles, even at high quantities, cannot trigger innate immune recognition and produce this 
form of cell death. Thus, in contrast to the previous view indicating productive and abortive 
HIV-1 infection as independent cytopathic events causing CD4 T-cell death (Cummins and 
Badley, 2010; Doitsh et al., 2010; Fevrier et al., 2011; Garg et al., 2012), these events are 
essentially linked in a single pathogenic cascade. Therefore, antiretroviral drugs such as 
AZT or raltergravir that do not directly prevent the death of abortively infected CD4 T cells 
(Doitsh et al., 2010), effectively inhibit HIV pathogenesis in vivo by blocking upstream 
events of productive HIV-1 infection. Caspase 1 inhibitors do not inhibit productive HIV-1 
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infection but block pyroptosis of abortively infected CD4 T cells (Doitsh et al., 2014). See 
also Supplemental Experimental Procedures.
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